Access to medicines

Access to medicines

One third of the world lacks  access to essential medicines.  In the poorest parts of Africa and Asia this figure rises to a half of the population. We challenge the high cost of medicines and the absence of treatment for many of the diseases affecting ou

Too often  we cannot treat patients because the medicines are too expensive, or they are no longer produced.  Sometimes, the only drugs we have are highly toxic or ineffective and nobody is looking for a better cure. 
As a medical humanitarian organisation, it is fundamentally unacceptable that access to essential medicines is increasingly difficult, particularly for the most common global infectious diseases. 

 
$262 million subsidy should not go to pharma giants Pfizer and GSK for pneumococcal vaccine [Photo: MSF]
Access to medicines

MSF: $262 million subsidy should not go to pharma giants Pfizer and GSK for pneumococcal vaccine

Press Release 3 Dec 2019
 
Mohamed Kalil is MSF’s humanitarian affairs advisor [Photo: Abdalle Mumin/MSF]
Access to Healthcare

Somalia: “Floods have left people so vulnerable that it’s a dilemma to decide whose needs are the greatest”

Stories from the Frontline 19 Nov 2019
 
New Ebola Vaccine [Photo: Gabriella Bianchi/MSF]
Access to medicines

Ebola in DRC: “We hope this vaccine will give us more options for future outbreaks”

Article 13 Nov 2019
 
Mundri Community Outreach [Photo: Tom Casey/MSF]
Access to Healthcare

“I’m really very proud because I’m saving my community” – Treating the three main killers in South Sudan

Project Update 9 Nov 2019
 
Floods in Somalia
Access to Healthcare

MSF responds to flooding in Somalia

Press Release 6 Nov 2019
 
Annie Kashung, MSF’s medical activity manager [Photo: Igor Barbero/MSF]
Access to Healthcare

Malaria outbreak in North Darfur, Sudan

Interview 4 Nov 2019